Evidence map›Paper›PMID 42037564›Full record

ArticleMycoses2026

Environmental Circulation of Aspergillus fumigatus With Reduced Susceptibility to Agricultural Triazole in Brazil: Clonal Dissemination of Potentially Resistant Genotypes.

Dality Keffelen de Barros Rodrigues, Manuel Leeuwerik, Balázs Brankovics, Wellington Santos Fava, James Venturini, Wieland Meyer, Teppei Arai, Hidetaka Majima, Akira Watanabe, Marcia de Souza Carvalho Melhem

Abstract read
In one paragraph

Article in Mycoses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dality Keffelen de Barros RodriguesFederal University of Mato Grosso do Sul, Campo Grande, Brazil.ORCID https://orcid.org/0000-0003-0835-0948
Manuel LeeuwerikWesterdijk Fungal Biodiversity Institute, Utrecht, the Netherlands.ORCID https://orcid.org/0009-0004-9658-1117
Balázs BrankovicsWesterdijk Fungal Biodiversity Institute, Utrecht, the Netherlands.ORCID https://orcid.org/0000-0003-0536-7787
Wellington Santos FavaFederal University of Mato Grosso do Sul, Campo Grande, Brazil.ORCID https://orcid.org/0000-0002-3608-0503
James VenturiniFederal University of Mato Grosso do Sul, Campo Grande, Brazil.ORCID https://orcid.org/0000-0003-0035-2439
Wieland MeyerWesterdijk Fungal Biodiversity Institute, Utrecht, the Netherlands.ORCID https://orcid.org/0000-0001-9933-8340
Teppei AraiMedical Mycology Research Center, Chiba University, Chiba, Japan.ORCID https://orcid.org/0000-0002-2798-5829
Hidetaka MajimaMedical Mycology Research Center, Chiba University, Chiba, Japan.ORCID https://orcid.org/0000-0001-9988-021X
Akira WatanabeMedical Mycology Research Center, Chiba University, Chiba, Japan.ORCID https://orcid.org/0000-0002-3057-2937
Marcia de Souza Carvalho MelhemFederal University of Mato Grosso do Sul, Campo Grande, Brazil.ORCID https://orcid.org/0000-0002-1335-8808

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 201422/2024-7Conselho Nacional de Desenvolvimento Científico e Tecnológico 443813/2023-0Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.658397/2021-00Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.819536/2023-00
6 · The paper itself

Abstract

backgroundAspergillus fumigatus resistance to triazole antifungals poses an increasing global health concern. Moreover, the cross-resistance between azole antifungal agents used in clinical settings and those applied in agriculture has become an important emerging issue.

objectivesIn this study, we investigated the five environmental A. fumigatus strains showing reduced susceptibility to tebuconazole.

methodsFungal strains were recovered from air samples collected around the homes of two patients with suspected aspergillosis caused by resistant isolates. Species identification was performed by sequencing the β-tubulin gene, and minimum inhibitory concentrations were determined by broth microdilution. The cyp51A gene was sequenced to detect mutations, and CRISPR-Cas9 genome editing was employed to investigate their influence on susceptibility patterns. Microsatellite genotyping was performed to assess genetic variability, followed by whole genome sequencing and single nucleotide polymorphism analysis.

resultsThe environmental strains presented the same cyp51A genotype characterised by the M172V substitution and silent mutations. Microsatellite genotyping and whole genome sequencing confirmed that the strains were clonal. Functional validation demonstrated that the M172V and silent mutations partially contribute to reduced susceptibility to tebuconazole but are not the main mechanism of resistance involved. Analysis of polymorphisms in genes other than cyp51A revealed no resistance-conferring mutations.

conclusionsThe findings described herein suggest the possibility of local clonal dissemination of environmental strains under selective pressure from agricultural azoles in a major agribusiness region of the Midwest of Brazil. This study highlights the silent spread of potentially resistant genotypes in urban areas and reinforces the need for environmental surveillance and expanded genomic monitoring in South America.

Indexed as

Antifungal AgentsAspergillus fumigatusDrug Resistance, FungalEnvironmental MicrobiologyTriazolesAspergillosisBrazilCytochrome P-450 Enzyme SystemFungal ProteinsGenotypeHumansMicrobial Sensitivity TestsMicrosatellite RepeatsMutationPolymorphism, Single NucleotideWhole Genome SequencingAntifungal Agentscytochrome P-450 CYP51A, AspergillusCytochrome P-450 Enzyme SystemFungal ProteinstebuconazoleTriazolesantifungal drug resistanceCRISPR‐Cas systemsCYP51 enzymesmicrosatellitestebuconazolewhole genome sequencing

Identifiers

PMID42037564
PMCPMC13112329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.